RSCH.JK PT Charlie Hospital Semarang Tbk
- Market cap
- IDR 1.22T
- P/E
- -
- P/B
- -
- ROE
- -12.6%
- Dividend yield
- -
- Fundamental score
- 0.7/5
Ratios use the latest price and the fiscal year ending Dec 2025.
Is RSCH.JK undervalued?
Graham numberThe Graham number of PT Charlie Hospital Semarang Tbk cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
PT Charlie Hospital Semarang Tbk fundamental analysis
2 of 21 checks passedROE 0/2
Low return on equity (-12.6%), below 10%.
ROA 0/1
Return on assets (-8.1%) is below the industry median (2.5%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (-367.5%) is below the industry median (28.6%).
Revenue Growth 2/2
Revenue grew 51.3% a year over the past 3 years.
Short-term Liquidity 0/1
Current assets do not cover short-term liabilities.
Long-term Liabilities 0/1
Current assets do not cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (30.5%), 40% or less.
Debt Trend 0/1
Debt to equity history is shorter than 5 years.
Cash Runway 0/2
Cash runway cannot be calculated.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book is negative or not available.
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
PT Charlie Hospital Semarang Tbk stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About PT Charlie Hospital Semarang Tbk
PT Charlie Hospital Semarang Tbk operates private hospitals in Indonesia. It operates through Healthcare Services, Construction Services, and Construction Materials Trading segments. The company's hospitals offer outpatients and inpatient services, including a 24-hour emergency room, specialist polyclinic services, central surgical installation services, intensive care units, Perina, laboratory services, radiology services, pharmacy services, medical checkup and support serv…
Full company profilePT Charlie Hospital Semarang Tbk financial statements
PT Charlie Hospital Semarang Tbk annual financial statements
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | 33.0B | 42.2B | 48.5B | 114B |
| Gross Profit | 3.70B | 11.9B | 13.9B | 19.0B |
| Operating Income | -8.80B | -1.42B | -3.14B | -11.2B |
| Net Income | -7.35B | -1.11B | -3.51B | -16.4B |
| EPS | -2.78 | -0.42 | -1.33 | -6.20 |
| Balance Sheet | ||||
| Total Assets | 91.0B | 154B | 192B | 203B |
| Total Liabilities | 53.4B | 3.97B | 45.5B | 72.0B |
| Shareholders' Equity | 37.6B | 150B | 147B | 131B |
| Cash & Short-term Investments | 8.68B | 1.80B | 1.81B | 4.00B |
| Cash Flow | ||||
| Operating Cash Flow | -1.46B | 2.96B | 4.31B | -6.19B |
| Capital Expenditure | 14.6B | 74.5B | 44.5B | 43.6B |
| Ratios | ||||
| ROE | -19.6% | -0.7% | -2.4% | -12.6% |
| ROA | -8.1% | -0.7% | -1.8% | -8.1% |
| Net Profit Margin | -22.3% | -2.6% | -7.2% | -14.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
PT Charlie Hospital Semarang Tbk dividends
PT Charlie Hospital Semarang Tbk has not paid dividends in the last 4 fiscal years.
Who owns PT Charlie Hospital Semarang Tbk
- Insiders 80.00%
- Institutions 0.00%
- Public & others 20.00%
- Shares outstanding 2.65B
- Free float 530M
PT Charlie Hospital Semarang Tbk company profile
- Company name
- PT Charlie Hospital Semarang Tbk
- Ticker
- RSCH.JK
- Exchange
- Jakarta Exchange
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Employees
- 214
- Fiscal year end
- December
- Address
- JaIan Raya Ngabean, Kendal, Indonesia, 51381
- Phone
- 62 24 8600 5000
- Website
- charliehospital.co.id
About PT Charlie Hospital Semarang Tbk
PT Charlie Hospital Semarang Tbk operates private hospitals in Indonesia. It operates through Healthcare Services, Construction Services, and Construction Materials Trading segments. The company's hospitals offer outpatients and inpatient services, including a 24-hour emergency room, specialist polyclinic services, central surgical installation services, intensive care units, Perina, laboratory services, radiology services, pharmacy services, medical checkup and support services, wellness centers, and other supporting facilities. It also engages in the construction, maintenance, and reconstruction of residential, office, industrial, commercial, healthcare, educational, lodging, entertainment/sports, and other buildings; and trading of construction materials. The company was founded in 2019 and is headquartered in Kendal, Indonesia. PT Charlie Hospital Semarang Tbk operates as a subsidiary of PT Wahyu Agung.
PT Charlie Hospital Semarang Tbk management
4- Mr. H. JuniantoPresident Director · born 1972
- Ms. Sri MulyaningsihDirector of Finance & Director · born 1973
- Catur Asih PuspitasariHead of the Internal Audit Unit
- Nur AzizahCorporate Secretary